相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Impact of Severe Acute Respiratory Syndrome Coronavirus 2 Viral Load on Risk of Intubation and Mortality Among Hospitalized Patients With Coronavirus Disease 2019
Reed Magleby et al.
CLINICAL INFECTIOUS DISEASES (2021)
Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro
Manli Wang et al.
CELL RESEARCH (2020)
Comparative Effectiveness of Combined Favipiravir and Oseltamivir Therapy Versus Oseltamivir Monotherapy in Critically Ill Patients With Influenza Virus Infection
Yeming Wang et al.
JOURNAL OF INFECTIOUS DISEASES (2020)
Therapeutic options for the 2019 novel coronavirus (2019-nCoV)
Guangdi Li et al.
NATURE REVIEWS DRUG DISCOVERY (2020)
Another Decade, Another Coronavirus
Stanley Perlman
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Favipiravir, an anti-influenza drug against life-threatening RNA virus infections
Kimiyasu Shiraki et al.
PHARMACOLOGY & THERAPEUTICS (2020)
Prioritization of Anti-SARS-Cov-2 Drug Repurposing Opportunities Based on Plasma and Target Site Concentrations Derived from their Established Human Pharmacokinetics
Usman Arshad et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2020)
Response to Dose Rationale for Favipiravir Use in Patients Infected With SARS-CoV-2
Yin-Xiao Du et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2020)
Favipiravir: Pharmacokinetics and Concerns About Clinical Trials for 2019-nCoV Infection
Du Yin-Xiao et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2020)
Probable Pangolin Origin of SARS-CoV-2 Associated with the COVID-19 Outbreak (vol 30, 1346.e1, 2020)
Tao Zhang et al.
CURRENT BIOLOGY (2020)
Early antiviral treatment contributes to alleviate the severity and improve the prognosis of patients with novel coronavirus disease (COVID-19)
J. Wu et al.
JOURNAL OF INTERNAL MEDICINE (2020)
Use of antiviral drugs to reduce COVID-19 transmission
Oriol Mitja et al.
LANCET GLOBAL HEALTH (2020)
A Trial of Lopinavir-Ritonavir in Adults Hospitalized with Severe Covid-19
B. Cao et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
A prospect on the use of antiviral drugs to control local outbreaks of COVID-19
Andrea Torneri et al.
BMC MEDICINE (2020)
Spatial and temporal dynamics of SARS-CoV-2 in COVID-19 patients: A systematic review and meta-analysis
Anne Weiss et al.
EBIOMEDICINE (2020)
The Rationale for Potential Pharmacotherapy of COVID-19
Maha Saber-Ayad et al.
PHARMACEUTICALS (2020)
Discovering drugs to treat coronavirus disease 2019 (COVID-19)
Liying Dong et al.
DRUG DISCOVERIES AND THERAPEUTICS (2020)
Influenza virus polymerase inhibitors in clinical development
Frederick G. Hayden et al.
CURRENT OPINION IN INFECTIOUS DISEASES (2019)
Favipiravir as a potential countermeasure against neglected and emerging RNA viruses
Leen Delang et al.
ANTIVIRAL RESEARCH (2018)
The mechanism of resistance to favipiravir in influenza
Daniel H. Goldhill et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
Favipiravir (T-705), a broad spectrum inhibitor of viral RNA polymerase
Yousuke Furuta et al.
PROCEEDINGS OF THE JAPAN ACADEMY SERIES B-PHYSICAL AND BIOLOGICAL SCIENCES (2017)
Clinical and Virological Characteristics of Ebola Virus Disease Patients Treated With Favipiravir (T-705)-Sierra Leone, 2014
Chang-Qing Bai et al.
CLINICAL INFECTIOUS DISEASES (2016)
Ebola Virus Infection: Review of the Pharmacokinetic and Pharmacodynamic Properties of Drugs Considered for Testing in Human Efficacy Trials
Vincent Madelain et al.
CLINICAL PHARMACOKINETICS (2016)
Favipiravir: A New Medication for the Ebola Virus Disease Pandemic
Takashi Nagata et al.
DISASTER MEDICINE AND PUBLIC HEALTH PREPAREDNESS (2015)
Broad Spectrum Antiviral Activity of Favipiravir (T-705): Protection from Highly Lethal Inhalational Rift Valley Fever
Amy L. Caroline et al.
PLOS NEGLECTED TROPICAL DISEASES (2014)
Favipiravir (T-705), a novel viral RNA polymerase inhibitor
Yousuke Furuta et al.
ANTIVIRAL RESEARCH (2013)
T-705 (Favipiravir) Induces Lethal Mutagenesis in Influenza A H1N1 Viruses In Vitro
Tatiana Baranovich et al.
JOURNAL OF VIROLOGY (2013)
The Ambiguous Base-Pairing and High Substrate Efficiency of T-705 (Favipiravir) Ribofuranosyl 5′-Triphosphate towards Influenza A Virus Polymerase
Zhinan Jin et al.
PLOS ONE (2013)
Human liver aldehyde oxidase: Inhibition by 239 drugs
RS Obach et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2004)
分享论文
